During Gynecologic Cancer Awareness Month, we focus on the products of our HPV diagnostic portfolio.
September is Gynecologic Cancer Awareness Month. There are 5 types of gynecological cancer - uterine, ovarian, cervical, vulvar and vaginal. Cervical cancer is one of the most common types of gynecological cancer.
Bulgaria is one of the countries in the EU with the highest rates of morbidity and mortality of cervical cancer. The most common reason for the development of cervical cancer is infection with high-risk genotypes of Human Papillomavirus (HPV). According to World Health Organization recommendations, the best way to reduce the number of patients and deaths is to implement an adequate screening program, which includes a cytology test and a HPV DNA test.
We at RIDACOM believe that good public awareness and accessibility to quality diagnosis are of the utmost importance for the early detection and prevention of this disease. In support of the campaign to combat and prevent gynecological cancer, we present to your attention the products of our Papillomavirus (HPV) Diagnostic Portfolio. We also offer accompanying products for liquid based cytology and mutation detection genes in the BRCA1 and BRCA2 genes most commonly associated with a predisposition to ovarian or breast cancer.Take advantage of our special offers for purchasing Molecular Diagnostic Kits with discounts from 10% to 25% until 10.10.2018.
Do not hesitate to request a free demonstration of the GeneNav™ HPV qPCR Kits product line at your laboratory.
Get acquainted with the Human Papillomavirus (HPV) Molecular Diagnostics Catalog with detailed campaign information and contact us to get our price quote!